These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

822 related items for PubMed ID: 8708717

  • 1. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer.
    Hartung G, Hofheinz RD, Wein A, Riedel C, Rost A, Fritze D, Kreuser ED, Drees M, Kühnel J, Hehlmann R, Queisser W.
    Onkologie; 2001 Oct; 24(5):457-62. PubMed ID: 11694772
    [Abstract] [Full Text] [Related]

  • 3. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    Köhne CH, Wils J, Lorenz M, Schöffski P, Voigtmann R, Bokemeyer C, Lutz M, Kleeberg C, Ridwelski K, Souchon R, El-Serafi M, Weiss U, Burkhard O, Rückle H, Lichnitser M, Langenbuch T, Scheithauer W, Baron B, Couvreur ML, Schmoll HJ, European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    J Clin Oncol; 2003 Oct 15; 21(20):3721-8. PubMed ID: 12963704
    [Abstract] [Full Text] [Related]

  • 4. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
    Köhne CH, Wilke H, Hecker H, Schöffski P, Käufer C, Rauschecker H, Andreesen R, Ohl U, Lange HJ, Klaassen U.
    Ann Oncol; 1995 May 15; 6(5):461-6. PubMed ID: 7669711
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
    Rosati G, Tucci A, Rinaldi A, Colarusso D, Pizza C, Reggiardo G, Manzione L.
    Oncology; 2004 May 15; 66(5):371-8. PubMed ID: 15331924
    [Abstract] [Full Text] [Related]

  • 7. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma.
    Kallen KJ, Hofmann MA, Timm A, Gödderz W, Galle PR, Heike M.
    Z Gastroenterol; 2000 Feb 15; 38(2):153-7. PubMed ID: 10721170
    [Abstract] [Full Text] [Related]

  • 8. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P.
    Cancer Chemother Pharmacol; 1996 Feb 15; 38(3):292-7. PubMed ID: 8646806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: a multicentre phase II trial.
    Kuhfahl J, Steinbrecher C, Wagner T, Wagner H, Fritze D, Link H, Schulte F, Pichlmeier U, Kreuser ED.
    Onkologie; 2004 Oct 15; 27(5):449-54. PubMed ID: 15585974
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
    de Gramont A, Bosset JF, Milan C, Rougier P, Bouché O, Etienne PL, Morvan F, Louvet C, Guillot T, François E, Bedenne L.
    J Clin Oncol; 1997 Feb 15; 15(2):808-15. PubMed ID: 9053508
    [Abstract] [Full Text] [Related]

  • 15. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
    Köhne CH, Schöffski P, Wilke H, Käufer C, Andreesen R, Ohl U, Klaasen U, Westerhausen M, Hiddemann W, Schott G, Harstick A, Bade J, Horster A, Schubert U, Hecker H, Dörken B, Schmoll HJ.
    J Clin Oncol; 1998 Feb 15; 16(2):418-26. PubMed ID: 9469324
    [Abstract] [Full Text] [Related]

  • 16. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
    O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB.
    J Clin Oncol; 2001 May 01; 19(9):2413-21. PubMed ID: 11331320
    [Abstract] [Full Text] [Related]

  • 17. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
    Hofheinz RD, Hartung G, Samel S, Hochhaus A, Pichlmeier U, Post S, Hehlmann R, Queisser W.
    Onkologie; 2002 Jun 01; 25(3):255-60. PubMed ID: 12119460
    [Abstract] [Full Text] [Related]

  • 18. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
    Hartmann JT, Köhne CH, Schmoll HJ, Daikeler T, Kanz L, Bokemeyer C.
    Oncology; 1998 Jun 01; 55(4):320-5. PubMed ID: 9663421
    [Abstract] [Full Text] [Related]

  • 19. Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.
    Köhne CH, Hiddemann W, Schüller J, Weiss J, Lohrmann HP, Schmitz-Hübner U, Bodenstein H, Schöber C, Wilke H, Grem J.
    J Clin Oncol; 1995 May 01; 13(5):1201-8. PubMed ID: 7738622
    [Abstract] [Full Text] [Related]

  • 20. Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).
    Wein A, Siebler J, Wolff K, Ostermeier N, Busse D, Hagel A, Koch F, Merx K, Neurath MF, Hofheinz RD.
    Anticancer Res; 2017 Jul 01; 37(7):3771-3779. PubMed ID: 28668873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.